PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
73.47%
Positive revenue growth while MAXN is negative. John Neff might see a notable competitive edge here.
212.90%
Gross profit growth above 1.5x MAXN's 73.39%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
37.68%
EBIT growth 50-75% of MAXN's 71.83%. Martin Whitman would suspect suboptimal resource allocation.
86.36%
Operating income growth 1.25-1.5x MAXN's 66.50%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
42.07%
Net income growth at 50-75% of MAXN's 73.10%. Martin Whitman would question fundamental disadvantages in expenses or demand.
43.14%
EPS growth of 43.14% while MAXN is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
43.14%
Diluted EPS growth at 50-75% of MAXN's 73.09%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.09%
Share change of 0.09% while MAXN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.09%
Diluted share change of 0.09% while MAXN is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
57.23%
OCF growth at 50-75% of MAXN's 93.92%. Martin Whitman would question if the firm lags in monetizing sales effectively.
45.43%
FCF growth under 50% of MAXN's 91.23%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
456.78%
Positive 10Y revenue/share CAGR while MAXN is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-26.49%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-2.58%
Negative 3Y CAGR while MAXN stands at 7.06%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-1063.10%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-523.38%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-490.23%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-311.40%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
92.23%
Positive 5Y CAGR while MAXN is negative. John Neff might view this as a strong mid-term relative advantage.
-132.84%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
33.48%
Positive growth while MAXN is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
-22.74%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
3.74%
Positive short-term equity growth while MAXN is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.80%
Our AR growth while MAXN is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-4.45%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-2.01%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.03%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
2.98%
We have some new debt while MAXN reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-10.37%
Our R&D shrinks while MAXN invests at 3.39%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-5.45%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.